IL-1β-driven osteoclastogenic Tregs accelerate bone erosion in arthritis

Area of Science:

• Immunology
• Rheumatology
• Bone Biology

Background:

• Interleukin-1 beta (IL-1β) is a key proinflammatory cytokine involved in immune responses.
• Regulatory T cells (Tregs) are crucial for immune homeostasis but can be dysregulated in autoimmune diseases like arthritis.

Purpose of the Study:

• To investigate the role of IL-1β in inducing osteoclastogenic capacity in Tregs.
• To determine the therapeutic potential of IL-1β blockade in autoimmune arthritis, focusing on bone erosion.

Main Methods:

• Utilized Il1rn-/- mice with joint inflammation to model arthritis.
• Administered IL-1β blockade and assessed disease parameters, including bone erosion.
• Analyzed synovial CD4+Foxp3+ Tregs for RANKL expression and osteoclast differentiation capacity.
• Investigated human Tregs from rheumatoid arthritis patients for analogous changes.

Main Results:

• IL-1β blockade was more effective in early versus established arthritis, particularly in reducing bone erosion.
• Synovial Tregs in Il1rn-/- mice showed aberrant RANKL expression and promoted osteoclast differentiation.
• Both Il1rn-/- and wild-type Tregs treated with IL-1β accelerated bone erosion upon adoptive transfer.
• Human Tregs from rheumatoid arthritis patients displayed similar RANKL-expressing phenotypes.

Conclusions:

• IL-1β induces osteoclastogenic capacity in Tregs, contributing significantly to bone erosion in arthritis.
• Targeting IL-1β early in the disease course may be a promising therapeutic strategy for managing arthritis-associated bone damage.